Omega-3 fatty acids: potential role in the management of early Alzheimer’s disease

References

• JichaGACarrSAConceptual Evolution in Alzheimer’s Disease: Implications for Understanding the Clinical Phenotype of Progressive Neurodegenerative DiseaseJ Alzheimers Dis201019125327220061643
   PubMed Web of Science ®Google Scholar
• Alzheimer’s disease facts and figuresAlzheimers Dement20095323427019426951
   PubMed Web of Science ®Google Scholar
• McKhannGDrachmanDFolsteinMKatzmanRPriceDStadlanEMClinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s DiseaseNeurology19843479399446610841
   PubMed Web of Science ®Google Scholar
• Consensus recommendations for the postmortem diagnosis of Alzheimer’s disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer’s DiseaseNeurobiol Aging1997184 SupplS1S29330978
   PubMed Web of Science ®Google Scholar
• BraakHBraakENeuropathological stageing of Alzheimer-related changesActa Neuropathol (Berl)19918242392591759558
   PubMed Web of Science ®Google Scholar
• MirraSSHeymanAMcKeelDThe Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s diseaseNeurology19914144794862011243
   PubMed Web of Science ®Google Scholar
• ColeGMMaQLFrautschySAOmega-3 fatty acids and dementiaProstaglandins Leukot Essent Fatty Acids2009812–321322119523795
   PubMed Web of Science ®Google Scholar
• CunnaneSCPlourdeMPifferiFBeginMFeartCBarberger-GateauPFish, docosahexaenoic acid and Alzheimer’s diseaseProg Lipid Res200948523925619362576
   PubMed Web of Science ®Google Scholar
• BoudraultCBazinetRPMaDWExperimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer’s diseaseJ Nutr Biochem200920111018824343
   PubMed Web of Science ®Google Scholar
• HooijmansCRKiliaanAJFatty acids, lipid metabolism and Alzheimer pathologyEur J Pharmacol2008585117619618378224
   PubMed Web of Science ®Google Scholar
• MarkesberyWRKryscioRJLovellMAMorrowJDLipid peroxidation is an early event in the brain in amnestic mild cognitive impairmentAnn Neurol200558573073516240347
   PubMed Web of Science ®Google Scholar
• MontineTJMorrowJDFatty acid oxidation in the pathogenesis of Alzheimer’s diseaseAm J Pathol200516651283128915855630
   PubMed Web of Science ®Google Scholar
• LukiwWJBazanNGDocosahexaenoic acid and the aging brainJ Nutr2008138122510251419022980
   PubMed Web of Science ®Google Scholar
• MazzaMPomponiMJaniriLBriaPMazzaSOmega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overviewProg Neuropsychopharmacol Biol Psychiatry2007311122616938373
   PubMed Web of Science ®Google Scholar
• WassallSRBrzustowiczMRShaikhSRCherezovVCaffreyMStillwellWOrder from disorder, corralling cholesterol with chaotic lipids. The role of polyunsaturated lipids in membrane raft formationChem Phys Lipids20041321798815530450
   PubMed Web of Science ®Google Scholar
• RussoGLDietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular preventionBiochem Pharmacol200977693794619022225
   PubMed Web of Science ®Google Scholar
• YehudaSRabinovitzSMostofskyDIEssential fatty acids and the brain: from infancy to agingNeurobiol Aging200526Suppl 19810216226347
   PubMed Web of Science ®Google Scholar
• GamohSHashimotoMSugiokaKChronic administration of docosahexaenoic acid improves reference memory-related learning ability in young ratsNeuroscience199993123724110430487
   PubMed Web of Science ®Google Scholar
• KawakitaEHashimotoMShidoODocosahexaenoic acid promotes neurogenesis in vitro and in vivoNeuroscience2006139399199716527422
   PubMed Web of Science ®Google Scholar
• KempermannGKuhnHGGageFHMore hippocampal neurons in adult mice living in an enriched environmentNature199738666244934959087407
   PubMed Web of Science ®Google Scholar
• KatakuraMHashimotoMShahdatHMDocosahexaenoic acid promotes neuronal differentiation by regulating basic helix-loop-helix transcription factors and cell cycle in neural stem cellsNeuroscience2009160365166019272428
   PubMed Web of Science ®Google Scholar
• ConklinSMGianarosPJBrownSMLong-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adultsNeurosci Lett2007421320921217574755
   PubMed Web of Science ®Google Scholar
• BarnesJScahillRISchottJMFrostCRossorMNFoxNCDoes Alzheimer’s disease affect hippocampal asymmetry? Evidence from a cross-sectional and longitudinal volumetric MRI studyDement Geriatr Cogn Disord2005195–633834415785035
   PubMed Web of Science ®Google Scholar
• BiglerEDTateDFMillerMJDementia, asymmetry of temporal lobe structures, and apolipoprotein E genotype: relationships to cerebral atrophy and neuropsychological impairmentJ Int Neuropsychol Soc20028792593312405544
   PubMed Web of Science ®Google Scholar
• GeroldiCLaaksoMPDeCarliCApolipoprotein E genotype and hippocampal asymmetry in Alzheimer’s disease: a volumetric MRI studyJ Neurol Neurosurg Psychiatry2000681939610601411
   PubMed Web of Science ®Google Scholar
• LikemanMAndersonVMStevensJMVisual assessment of atrophy on magnetic resonance imaging in the diagnosis of pathologically confirmed young-onset dementiasArch Neurol20056291410141516157748
   PubMedGoogle Scholar
• ShiFLiuBZhouYYuCJiangTHippocampal volume and asymmetry in mild cognitive impairment and Alzheimer’s disease: Meta-analyses of MRI studiesHippocampus200919111055106419309039
   PubMed Web of Science ®Google Scholar
• TiemeierHvan TuijlHRHofmanAKiliaanAJBretelerMMPlasma fatty acid composition and depression are associated in the elderly: the Rotterdam StudyAm J Clin Nutr2003781404612816769
   PubMed Web of Science ®Google Scholar
• BazanNGNeuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stressBrain Pathol200515215916615912889
   PubMed Web of Science ®Google Scholar
• LukiwWJCuiJGMarcheselliVLA role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer diseaseJ Clin Invest2005115102774278316151530
   PubMed Web of Science ®Google Scholar
• FarooquiAAHorrocksLAPhospholipase A2-generated lipid mediators in the brain: the good, the bad, and the uglyNeuroscientist200612324526016684969
   PubMed Web of Science ®Google Scholar
• ForlenzaOVSchaefferELGattazWFThe role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer’s diseaseJ Neural Transm2007114223123817131232
   PubMed Web of Science ®Google Scholar
• GattazWFForlenzaOVTalibLLBarbosaNRBottinoCMPlatelet phospholipase A(2) activity in Alzheimer’s disease and mild cognitive impairmentJ Neural Transm2004111559160115088152
   PubMed Web of Science ®Google Scholar
• SchaefferELForlenzaOVGattazWFPhospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer diseasePsychopharmacology (Berl)20092021–3375118853146
   PubMed Web of Science ®Google Scholar
• SmesnySSteinSWillhardtILaschJSauerHDecreased phospholipase A2 activity in cerebrospinal fluid of patients with dementiaJ Neural Transm200811581173117918584113
   PubMed Web of Science ®Google Scholar
• SunGYXuJJensenMDSimonyiAPhospholipase A2 in the central nervous system: implications for neurodegenerative diseasesJ Lipid Res200445220521314657205
   PubMed Web of Science ®Google Scholar
• MontineTJMontineKSMcMahanWMarkesberyWRQuinnJFMorrowJDF2-isoprostanes in Alzheimer and other neurodegenerative diseasesAntioxid Redox Signal200571–226927515650414
   PubMed Web of Science ®Google Scholar
• MontineTJBealMFCudkowiczMEIncreased CSF F2-isoprostane concentration in probable ADNeurology199952356256510025788
   PubMed Web of Science ®Google Scholar
• MontineTJMarkesberyWRMorrowJDRobertsLJ2ndCerebrospinal fluid F2-isoprostane levels are increased in Alzheimer’s diseaseAnn Neurol19984434104139749613
   PubMed Web of Science ®Google Scholar
• Nourooz-ZadehJLiuEHYhlenBAnggardEEHalliwellBF4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer’s diseaseJ Neurochem19997227347409930747
   PubMed Web of Science ®Google Scholar
• PraticoDVMYLTrojanowskiJQRokachJFitzgeraldGAIncreased F2-isoprostanes in Alzheimer’s disease: evidence for enhanced lipid peroxidation in vivoFASEB J19981215177717839837868
   PubMed Web of Science ®Google Scholar
• ReichEEMarkesberyWRRobertsLJ2ndSwiftLLMorrowJDMontineTJQuantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer’s diseaseAdv Exp Med Biol200150025325611764949
   PubMed Web of Science ®Google Scholar
• ReichEEMarkesberyWRRobertsLJ2ndSwiftLLMorrowJDMontineTJBrain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer’s diseaseAm J Pathol2001158129329711141503
   PubMed Web of Science ®Google Scholar
• HardyJHas the amyloid cascade hypothesis for Alzheimer’s disease been proved?Curr Alzheimer Res200631717316472206
   PubMedGoogle Scholar
• HardyJAHigginsGAAlzheimer’s disease: the amyloid cascade hypothesisScience199225650541841851566067
   PubMed Web of Science ®Google Scholar
• SelkoeDJSoluble oligomers of the amyloid beta-protein impair synaptic plasticity and behaviorBehav Brain Res2008192110611318359102
   PubMed Web of Science ®Google Scholar
• ColeSLVassarRBACE1 structure and function in health and Alzheimer’s diseaseCurr Alzheimer Res20085210012018393796
   PubMed Web of Science ®Google Scholar
• StockleyJHO’NeillCThe proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer’s disease brainBiochem Soc Trans200735(Pt 3):57457617511655
   PubMed Web of Science ®Google Scholar
• StockleyJHO’NeillCUnderstanding BACE1: essential protease for amyloid-beta production in Alzheimer’s diseaseCell Mol Life Sci200865203265328918695942
   PubMed Web of Science ®Google Scholar
• StockleyJHRavidRO’NeillCAltered beta-secretase enzyme kinetics and levels of both BACE1 and BACE2 in the Alzheimer’s disease brainFEBS Lett200658028–296550656017113083
   PubMed Web of Science ®Google Scholar
• WillemMLammichSHaassCFunction, regulation and therapeutic properties of beta-secretase (BACE1)Semin Cell Dev Biol200920217518219429494
   PubMed Web of Science ®Google Scholar
• HashimotoMShahdatHMYamashitaSDocosahexaenoic acid disrupts in vitro amyloid beta(1–40) fibrillation and concomitantly inhibits amyloid levels in cerebral cortex of Alzheimer’s disease model ratsJ Neurochem200810761634164619014387
   PubMed Web of Science ®Google Scholar
• HossainSHashimotoMKatakuraMMiwaKShimadaTShidoOMechanism of docosahexaenoic acid-induced inhibition of in vitro Abeta1-42 fibrillation and Abeta1-42-induced toxicity in SH-S5Y5 cellsJ Neurochem2009111256857919686246
   PubMed Web of Science ®Google Scholar
• EhehaltRKellerPHaassCThieleCSimonsKAmyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid raftsJ Cell Biol2003160111312312515826
   PubMed Web of Science ®Google Scholar
• GreenKNMartinez-CoriaHKhashwjiHDietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levelsJ Neurosci200727164385439517442823
   PubMed Web of Science ®Google Scholar
• OksmanMIivonenHHogyesEImpact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic miceNeurobiol Dis200623356357216765602
   PubMed Web of Science ®Google Scholar
• RiddellDRChristieGHussainIDingwallCCompartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid raftsCurr Biol200111161288129311525745
   PubMed Web of Science ®Google Scholar
• CalonFLimGPYangFDocosahexaenoic acid protects from dendritic pathology in an Alzheimer’s disease mouse modelNeuron200443563364515339646
   PubMed Web of Science ®Google Scholar
• LimGPCalonFMoriharaTA diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse modelJ Neurosci200525123032304015788759
   PubMed Web of Science ®Google Scholar
• HashimotoMHossainSAgdulHShidoODocosahexaenoic acid-induced amelioration on impairment of memory learning in amyloid beta-infused rats relates to the decreases of amyloid beta and cholesterol levels in detergent-insoluble membrane fractionsBiochim Biophys Acta200517381–3919816427803
   PubMed Web of Science ®Google Scholar
• HashimotoMHossainSShimadaTDocosahexaenoic acid provides protection from impairment of learning ability in Alzheimer’s disease model ratsJ Neurochem20028151084109112065621
   PubMed Web of Science ®Google Scholar
• HashimotoMTanabeYFujiiYKikutaTShibataHShidoOChronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused ratsJ Nutr2005135354955515735092
   PubMed Web of Science ®Google Scholar
• HashimotoMHossainSShimadaTShidoODocosahexaenoic acid-induced protective effect against impaired learning in amyloid beta-infused rats is associated with increased synaptosomal membrane fluidityClin Exp Pharmacol Physiol2006331093493917002670
   PubMed Web of Science ®Google Scholar
• de la TorreJCAlzheimer’s disease is a vasocognopathy: a new term to describe its natureNeurol Res200426551752415265269
   PubMed Web of Science ®Google Scholar
• EngelbergHPathogenic factors in vascular dementia and Alzheimer’s disease. Multiple actions of heparin that probably are beneficialDement Geriatr Cogn Disord2004183–427829815286460
   PubMed Web of Science ®Google Scholar
• WellerROCohenNRNicollJACerebrovascular disease and the pathophysiology of Alzheimer’s disease. Implications for therapyPanminerva Med200446423925115876980
   PubMed Web of Science ®Google Scholar
• YipAGMcKeeACGreenRCAPOE, vascular pathology, and the AD brainNeurology200565225926516043796
   PubMed Web of Science ®Google Scholar
• ZekryDHauwJJGoldGMixed dementia: epidemiology, diagnosis, and treatmentJ Am Geriatr Soc20028508:1431143812165002
   PubMed Web of Science ®Google Scholar
• HornstraGInfluence of dietary fat type on arterial thrombosis tendencyJ Nutr Health Aging20015316016611458286
   PubMedGoogle Scholar
• DimitrowPPJawienMPleiotropic, cardioprotective effects of omega-3 polyunsaturated fatty acidsMini Rev Med Chem2009991030103919689400
   PubMed Web of Science ®Google Scholar
• HeKFish, long-chain omega-3 polyunsaturated fatty acids and prevention of cardiovascular disease--eat fish or take fish oil supplement?Prog Cardiovasc Dis20095229511419732603
   PubMed Web of Science ®Google Scholar
• LavieCJMilaniRVMehraMRVenturaHOOmega-3 polyunsaturated fatty acids and cardiovascular diseasesJ Am Coll Cardiol200954758559419660687
   PubMed Web of Science ®Google Scholar
• MarikPEVaronJOmega-3 dietary supplements and the risk of cardiovascular events: a systematic reviewClin Cardiol200932736537219609891
   PubMed Web of Science ®Google Scholar
• MozaffarianDFish, n-3 fatty acids, and cardiovascular haemodynamicsJ Cardiovasc Med (Hagerstown)20078Suppl 1S23S2617876193
   PubMed Web of Science ®Google Scholar
• MozaffarianDFish, mercury, selenium and cardiovascular risk: current evidence and unanswered questionsInt J Environ Res Public Health2009661894191619578467
   PubMed Web of Science ®Google Scholar
• WillettWCThe role of dietary n-6 fatty acids in the prevention of cardiovascular diseaseJ Cardiovasc Med (Hagerstown)20078Suppl 1S42S4517876199
   PubMed Web of Science ®Google Scholar
• MarzoloMPBuGLipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer’s diseaseSemin Cell Dev Biol200920219120019041409
   PubMed Web of Science ®Google Scholar
• StefaniMLiguriGCholesterol in Alzheimer’s disease: unresolved questionsCurr Alzheimer Res200961152919199871
   PubMed Web of Science ®Google Scholar
• BuGApolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapyNat Rev Neurosci200910533334419339974
   PubMed Web of Science ®Google Scholar
• de ChavesEPNarayanaswamiVApolipoprotein E and cholesterol in aging and disease in the brainFuture Lipidol20083550553019649144
   PubMed Web of Science ®Google Scholar
• KimJBasakJMHoltzmanDMThe role of apolipoprotein E in Alzheimer’s diseaseNeuron200963328730319679070
   PubMed Web of Science ®Google Scholar
• SchipperHMApolipoprotein E: Implications for AD neurobiology, epidemiology and risk assessmentNeurobiol Aging292009
   Web of Science ®Google Scholar
• BeachTGWilsonJRSueLICircle of Willis atherosclerosis: association with Alzheimer’s disease, neuritic plaques and neurofibrillary tanglesActa Neuropathol20071131132117021755
   PubMed Web of Science ®Google Scholar
• HonigLSKukullWMayeuxRAtherosclerosis and AD: analysis of data from the US National Alzheimer’s Coordinating CenterNeurology200564349450015699381
   PubMed Web of Science ®Google Scholar
• RoherAEEshCKokjohnTACircle of willis atherosclerosis is a risk factor for sporadic Alzheimer’s diseaseArterioscler Thromb Vasc Biol200323112055206214512367
   PubMed Web of Science ®Google Scholar
• RoherAEEshCRahmanAKokjohnTABeachTGAtherosclerosis of cerebral arteries in Alzheimer diseaseStroke2004113511 Suppl 12623262715375298
   PubMed Web of Science ®Google Scholar
• CastanoEMPrelliFWisniewskiTFibrillogenesis in Alzheimer’s disease of amyloid beta peptides and apolipoprotein EBiochem J1995306(Pt 2):5996047534068
   PubMed Web of Science ®Google Scholar
• SotoCCastanoEMPrelliFKumarRABaumannMApolipoprotein E increases the fibrillogenic potential of synthetic peptides derived from Alzheimer’s, gelsolin and AA amyloidsFEBS Lett199537121101147672107
   PubMed Web of Science ®Google Scholar
• KalmijnSLaunerLJOttAWittemanJCHofmanABretelerMMDietary fat intake and the risk of incident dementia in the Rotterdam StudyAnn Neurol19974257767829392577
   PubMed Web of Science ®Google Scholar
• EngelhartMJGeerlingsMIRuitenbergADiet and risk of dementia: Does fat matter?: The Rotterdam StudyNeurology200259121915192112499483
   PubMed Web of Science ®Google Scholar
• ConquerJATierneyMCZecevicJBettgerWJFisherRHFatty acid analysis of blood plasma of patients with Alzheimer’s disease, other types of dementia, and cognitive impairmentLipids200035121305131211201991
   PubMed Web of Science ®Google Scholar
• LaurinDVerreaultRLindsayJDewaillyEHolubBJOmega-3 fatty acids and risk of cognitive impairment and dementiaJ Alzheimers Dis20035431532214624027
   PubMed Web of Science ®Google Scholar
• KrogerEVerreaultRCarmichaelPHOmega-3 fatty acids and risk of dementia: the Canadian Study of Health and AgingAm J Clin Nutr200990118419219474137
   PubMed Web of Science ®Google Scholar
• Barberger-GateauPLetenneurLDeschampsVPeresKDartiguesJFRenaudSFish, meat, and risk of dementia: cohort studyBMJ2002325737093293312399342
   PubMed Web of Science ®Google Scholar
• Barberger-GateauPRaffaitinCLetenneurLDietary patterns and risk of dementia: the Three-City cohort studyNeurology200769201921193017998483
   PubMed Web of Science ®Google Scholar
• OtsukaMYamaguchiKUekiASimilarities and differences between Alzheimer’s disease and vascular dementia from the viewpoint of nutritionAnn N Y Acad Sci200297715516112480746
   PubMed Web of Science ®Google Scholar
• TullyAMRocheHMDoyleRLow serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer’s disease: a case-control studyBr J Nutr200389448348912654166
   PubMed Web of Science ®Google Scholar
• MorrisMCEvansDABieniasJLConsumption of fish and n-3 fatty acids and risk of incident Alzheimer diseaseArch Neurol200360794094612873849
   PubMedGoogle Scholar
• MorrisMCEvansDATangneyCCBieniasJLWilsonRSFish consumption and cognitive decline with age in a large community studyArch Neurol200562121849185316216930
   PubMedGoogle Scholar
• HuangTLZandiPPTuckerKLBenefits of fatty fish on dementia risk are stronger for those without APOE epsilon4Neurology20056591409141416275829
   PubMed Web of Science ®Google Scholar
• SchaeferEJBongardVBeiserASPlasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart StudyArch Neurol200663111545155017101822
   PubMedGoogle Scholar
• BeydounMAKaufmanJSSatiaJARosamondWFolsomARPlasma n-3 fatty acids and the risk of cognitive decline in older adults: the Atherosclerosis Risk in Communities StudyAm J Clin Nutr20078541103111117413112
   PubMed Web of Science ®Google Scholar
• van GelderBMTijhuisMKalmijnSKromhoutDFish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: the Zutphen Elderly StudyAm J Clin Nutr20078541142114717413117
   PubMed Web of Science ®Google Scholar
• DangourADAllenEElbourneDFletcherARichardsMUauyRFish consumption and cognitive function among older people in the UK: baseline data from the OPAL studyJ Nutr Health Aging200913319820219262951
   PubMed Web of Science ®Google Scholar
• WhalleyLJDearyIJStarrJMn-3 Fatty acid erythrocyte membrane content, APOE varepsilon4, and cognitive variation: an observational follow-up study in late adulthoodAm J Clin Nutr200887244945418258638
   PubMed Web of Science ®Google Scholar
• BostonPFBennettAHorrobinDFBennettCNEthyl-EPA in Alzheimer’s disease – a pilot studyProstaglandins Leukot Essent Fatty Acids200471534134615380822
   PubMed Web of Science ®Google Scholar
• KotaniSSakaguchiEWarashinaSDietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunctionNeurosci Res200656215916416905216
   PubMed Web of Science ®Google Scholar
• Freund-LeviYEriksdotter-JonhagenMCederholmTOmega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trialArch Neurol200663101402140817030655
   PubMed Web of Science ®Google Scholar
• Freund-LeviYHjorthELindbergCEffects of omega-3 fatty acids on inflammatory markers in cerebrospinal fluid and plasma in Alzheimer’s disease: the OmegAD studyDement Geriatr Cogn Disord200927548149019439966
   PubMed Web of Science ®Google Scholar
• ChiuCCSuKPChengTCThe effects of omega-3 fatty acids monotherapy in Alzheimer’s disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled studyProg Neuropsychopharmacol Biol Psychiatry20083261538154418573585
   PubMed Web of Science ®Google Scholar